|
|
|
|
|
|
The latest neurology news from News Medical |
|
|
|
 | |
Discover the latest advancements in neuroscience research
Join the Bruker Neuroscience Online Summit 2025 on April 22 and 23, 2025, from 8AM to 10:30AM (PDT) each day. This free virtual event will feature expert speakers presenting their latest findings across six key areas of neuroscience, highlighting cutting-edge research using advanced imaging technologies to explore neuronal activity.
| |
|
|
| |  | | The cells with electrophysiological activity obtained at the University of the Basque Country (UPV/EHU) are opening up new avenues for the study of neurodegenerative diseases and the development of future autologous transplants. | | | | In an effort to understand how brain cells exchange chemical messages, scientists say they have successfully used a highly specialized microscope to capture more precise details of how one of the most common signaling molecules, glutamate, opens a channel and allows a flood of charged particles to enter. | | | | People with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower risk of dementia, including lower risk of Alzheimer's disease related dementia, shows a study published online today in the Journal of Neurology Neurosurgery & Psychiatry. | | | | People who have early signs of heart problems may also have changes in brain health that can be early signs of dementia, such as loss of brain volume, according to a meta-analysis published on March 26, 2025, online in Neurology, the medical journal of the American Academy of Neurology. | | | | People living in more disadvantaged neighborhoods may be more likely to develop dementia than people living in neighborhoods with fewer disadvantages, according to a study published on March 26, 2025, online in Neurology, the medical journal of the American Academy of Neurology. | | | | Neurizon Therapeutics Limited, a biotech company focused on neurodegenerative diseases, announced that the results of an independent study conducted in collaboration with Tessara Therapeutics will be presented by Dr. Mark Greenough, the group's Principal Scientist and Alzheimer’s expert. The presentation will take place at the AD/PD 2025 Advances in Sciences & Therapy conference in Vienna, Austria. | | | | The MetaVision3D tool transforms 2D tissue sections into 3D brain metabolome models, offering critical insights into metabolism and neurological diseases. | |
|
|
| |  | | How would you rate today's newsletter?
| |
|
|
|  | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
|